To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene C14orf119TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
436 supporting clones for gene C14orf119 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
DB114484 thymus .a-u 1 to 547 2 to 549   capped   548/548
(100 %)
3 diff
(99.5 %id)
DA534493 brain .a-u 2 to 575 2 to 575   capped   574/574
(100 %)
0 diff
(100 %id)
DA570810 whole embryo, mainly head .a-u 2 to 743 2 to 741   tiling clone, capped   740/747
(99 %)
3 diff
(99.6 %id)
DB124438 thymus .a-u 3 to 534 2 to 534   capped   533/533
(100 %)
2 diff
(99.7 %id)
BU153685 eye, retinoblastoma .a-u 18 to 927 20 to 928       909/930
(97 %)
14 diff
(98.5 %id)
AK024794   .a-u 30 to 1818 1 to 1787 exact tiling clone, available from FLJ, AAA Possibly primed on the genome, locally A rich (26/26 A in genome downstream of last aligned base) 1787/1787
(100 %)
5 diff
(99.8 %id)
DA674498   .a-u 64 to 590 2 to 528   capped   527/527
(100 %)
0 diff
(100 %id)
DA427392 colon .a-u 836 to 1402 2 to 568   tiling clone, capped   567/567
(100 %)
3 diff
(99.5 %id)
DB357610 whole embryo, mainly head .a-u 1255 to 1818 563 to 1       563/563
(100 %)
14 diff
(97.6 %id)
CN267283 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a-u 1660 to 1871 1 to 213   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 213/213
(100 %)
5 diff
(97.7 %id)
CR622831 Placenta Cot 25-normalized .b 1 to 1605 1 to 1605 exact tiling clone,   1605/1605
(100 %)
0 diff
(100 %id)
BX340152 Placenta Cot 25-normalized .b 1 to 885 1 to 886       886/886
(100 %)
10 diff
(98.9 %id)
BX346758 Placenta Cot 25-normalized .b 1 to 1025 1 to 1019 T2N P4X T5X A6X L8X ...     1019/1019
(100 %)
47 diff
(95.4 %id)
BX371204 Placenta Cot 25-normalized .b 1 to 933 1 to 927 S99X W105L D131X R139X G141X ...     927/932
(99 %)
10 diff
(99.0 %id)
BM562024 leukocyte .b 14 to 888 13 to 892       880/1116
(78 %)
17 diff
(98.5 %id)
DB040465 testis .b 73 to 617 2 to 546   capped   545/545
(100 %)
1 diff
(99.9 %id)
DB461057 testis .b 444 to 908 1 to 465       465/465
(100 %)
2 diff
(99.6 %id)
DA605680   .b 711 to 1265 2 to 556   capped   555/555
(100 %)
1 diff
(99.9 %id)
BE735514 adenocarcinoma, Pancreas .b 712 to 794 1 to 80       80/80
(100 %)
3 diff
(96.3 %id)
BU602708 mixed (pool of 40 RNAs) .b 724 to 1488 1 to 771       771/782
(98 %)
10 diff
(98.8 %id)
BU945574 mixed (pool of 40 RNAs) .b 724 to 1482 1 to 767       767/767
(100 %)
12 diff
(98.5 %id)
CR620909 T cells (Jurkat cell line) Cot10-normalized .b 725 to 1762 1 to 1038       1038/1038
(100 %)
0 diff
(100 %id)
BX326368 Placenta Cot 25-normalized .b 728 to 1605 1 to 877       877/877
(100 %)
24 diff
(97.3 %id)
BG120274 adenocarcinoma, cell line, Liver .b 729 to 1475 1 to 730       730/811
(90 %)
26 diff
(96.8 %id)
BM920993 pooled brain, lung, testis .b 731 to 1702 11 to 993       983/1042
(94 %)
28 diff
(97.4 %id)
BP354952   .b 737 to 1320 1 to 583       583/583
(100 %)
4 diff
(99.4 %id)
BU598274 mixed (pool of 40 RNAs) .b 738 to 1348 1 to 614       614/870
(70 %)
16 diff
(98.2 %id)
CB986100 Pooled-Glandular .b 738 to 1439 1 to 711       711/749
(94 %)
19 diff
(97.5 %id)
CD357462 Blood vessels - aorta, basilar and artery .b 738 to 1362 1 to 630       630/757
(83 %)
16 diff
(97.9 %id)
BC056255 lung .b 739 to 1789 1 to 1051   available from MGC, AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 1051/1051
(100 %)
4 diff
(99.7 %id)
BP203455 coronary artery .b 739 to 1310 1 to 573       573/579
(98 %)
21 diff
(96.4 %id)
AF061731 brain .b 740 to 1687 1 to 948       948/949
(99 %)
3 diff
(99.7 %id)
BF679029 Prostate .b 740 to 1381 1 to 637       637/866
(73 %)
10 diff
(98.9 %id)
BG428984 Kidney .b 740 to 1584 1 to 847       847/874
(96 %)
27 diff
(97.0 %id)
BG494747 lung, mucoepidermoid carcinoma .b 740 to 1446 1 to 709       709/719
(98 %)
7 diff
(99.1 %id)
BG547571 lung .b 740 to 1456 1 to 728       728/730
(99 %)
30 diff
(95.9 %id)
BG615732 embryonal carcinoma, testis .b 740 to 1507 1 to 772       772/789
(97 %)
24 diff
(97.0 %id)
DB473980 hippocampus .b 741 to 1225 1 to 485       485/486
(99 %)
1 diff
(99.8 %id)
DA517993 brain .b 742 to 1293 2 to 553   capped   552/552
(100 %)
0 diff
(100 %id)
BF666511 brain, primitive neuroectoderm .b 742 to 1387 1 to 643       643/745
(86 %)
10 diff
(98.7 %id)
BG540853 lung .b 742 to 1202 1 to 466       466/764
(60 %)
10 diff
(98.7 %id)
DW465039 Liver .b 743 to 1086 17 to 360       344/360
(95 %)
8 diff
(97.8 %id)
DB491602 hypothalamus .b 743 to 1135 1 to 393       393/393
(100 %)
4 diff
(99.0 %id)
DB492076 hypothalamus .b 743 to 1144 1 to 402       402/402
(100 %)
3 diff
(99.3 %id)
DB492734 hypothalamus .b 743 to 1203 1 to 461       461/461
(100 %)
2 diff
(99.6 %id)
CN427686 embryonic stem cells, cell lines H1, H7, andH9 .b 746 to 1109 1 to 364       364/364
(100 %)
2 diff
(99.5 %id)
CN427682 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 750 to 1029 1 to 280       280/280
(100 %)
1 diff
(99.7 %id)
CN427689 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 750 to 1461 7 to 718       712/718
(99 %)
6 diff
(99.2 %id)
ES315619 occipital scalp hair, skin .b 750 to 908 1 to 158       158/158
(100 %)
6 diff
(96.3 %id)
CD709364 normal nasopharynx .b 752 to 1305 31 to 584       554/584
(94 %)
6 diff
(99.0 %id)
BE567999 bladder, carcinoma, cell line .b 752 to 1441 1 to 684       684/868
(78 %)
33 diff
(96.2 %id)
BF131789 hypernephroma, Kidney .b 752 to 1166 1 to 419       419/557
(75 %)
12 diff
(97.9 %id)
BF675394 Prostate .b 755 to 1390 1 to 626       626/861
(72 %)
17 diff
(98.1 %id)
FN086401 breast carcinoma .b 756 to 837 1 to 81       81/87
(93 %)
8 diff
(90.9 %id)
CB986135 Pooled-Glandular .b 758 to 1287 1 to 543       543/901
(60 %)
25 diff
(97.3 %id)
CB984613 Pooled-Glandular .b 759 to 1576 1 to 825       825/829
(99 %)
21 diff
(97.5 %id)
BF247274 hypernephroma, Kidney .b 760 to 1444 1 to 688       688/915
(75 %)
43 diff
(95.4 %id)
BF208516 bladder, carcinoma, cell line .b 760 to 1447 1 to 677       677/857
(78 %)
25 diff
(97.1 %id)
BF670514 muscle (skeletal) .b 760 to 1474 1 to 702       702/855
(82 %)
36 diff
(95.8 %id)
BG571688 placenta .b 760 to 1617 1 to 866       866/867
(99 %)
23 diff
(97.4 %id)
BP210794 cerebellum .b 761 to 1342 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
CD687865 normal nasopharynx .b 761 to 1369 50 to 657       608/657
(92 %)
8 diff
(98.8 %id)
BE738091 brain, glioblastoma .b 761 to 1387 1 to 623       623/698
(89 %)
8 diff
(98.9 %id)
BF244898 brain, glioblastoma .b 761 to 1496 1 to 750       750/795
(94 %)
44 diff
(94.5 %id)
BG166336 hypernephroma, cell line, Kidney .b 761 to 1329 1 to 573       573/954
(60 %)
16 diff
(98.4 %id)
CB991094 placenta, pre-eclamptic placenta .b 761 to 1549 28 to 823       796/823
(96 %)
27 diff
(96.8 %id)
CB997720 placenta, pre-eclamptic placenta .b 761 to 1496 28 to 780       753/804
(93 %)
24 diff
(97.1 %id)
CB108476 Liver .b 761 to 1195 1 to 434       434/434
(100 %)
2 diff
(99.6 %id)
CB145568 Liver .b 761 to 1178 1 to 418       418/418
(100 %)
1 diff
(99.8 %id)
BP370654 testis .b 761 to 1343 1 to 582       582/582
(100 %)
4 diff
(99.4 %id)
DA022809   .b 762 to 1339 2 to 579   capped   578/578
(100 %)
0 diff
(100 %id)
CD704661 normal nasopharynx .b 762 to 1074 15 to 327       313/327
(95 %)
6 diff
(98.2 %id)
DA454966 tongue, tumor tissue .b 762 to 1001 2 to 241   capped   240/240
(100 %)
0 diff
(100 %id)
DB007780 cervix, tumor tissue .b 762 to 1323 2 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
FN172677 breast carcinoma .b 764 to 833 1 to 69       69/72
(95 %)
6 diff
(91.7 %id)
BU932548 mixed (pool of 40 RNAs) .b 764 to 1417 1 to 678       678/854
(79 %)
50 diff
(94.2 %id)
BF208848 bladder, carcinoma, cell line .b 765 to 1401 1 to 629       629/862
(72 %)
25 diff
(97.1 %id)
BG496983 lung, mucoepidermoid carcinoma .b 765 to 1579 1 to 827       765/836
(91 %)
26 diff
(96.9 %id)
BG529729 embryonal carcinoma, testis .b 765 to 1408 1 to 644       644/645
(99 %)
8 diff
(98.8 %id)
BG562507 Liver .b 765 to 1582 1 to 824       824/825
(99 %)
16 diff
(98.1 %id)
BG572310 placenta .b 765 to 1408 1 to 644       644/645
(99 %)
2 diff
(99.7 %id)
BG619553 placenta .b 765 to 1448 1 to 688       688/689
(99 %)
14 diff
(98.0 %id)
DA618628   .b 765 to 1348 2 to 586   capped   585/585
(100 %)
1 diff
(99.9 %id)
CD709064 normal nasopharynx .b 766 to 1441 23 to 698       676/698
(96 %)
6 diff
(99.2 %id)
BU657975 blood .b 766 to 1213 12 to 459       448/459
(97 %)
7 diff
(98.5 %id)
BF211807 bone marrow, from chronic myelogenous leukemia .b 767 to 1398 32 to 668       637/906
(70 %)
42 diff
(95.4 %id)
DN914818   .b 769 to 1342 1 to 574       574/574
(100 %)
3 diff
(99.5 %id)
DB479462 hippocampus .b 769 to 1236 1 to 468       468/468
(100 %)
1 diff
(99.8 %id)
BX099031 liver and spleen .b 770 to 1505 1 to 736       736/736
(100 %)
1 diff
(99.9 %id)
H73551 liver and spleen .b 770 to 1274 1 to 517       517/525
(98 %)
20 diff
(96.2 %id)
CB125024 Liver .b 772 to 1480 1 to 709       709/709
(100 %)
0 diff
(100 %id)
CB139878 Liver .b 772 to 1270 1 to 499       499/499
(100 %)
0 diff
(100 %id)
CB133578 Liver .b 772 to 1218 1 to 448       448/448
(100 %)
1 diff
(99.8 %id)
CB138991 Liver .b 772 to 1332 1 to 561       561/561
(100 %)
0 diff
(100 %id)
CB139058 Liver .b 772 to 1407 1 to 636       636/636
(100 %)
0 diff
(100 %id)
CB137082 Liver .b 772 to 1165 1 to 394       394/394
(100 %)
2 diff
(99.5 %id)
CB137111 Liver .b 772 to 1245 1 to 474       474/474
(100 %)
0 diff
(100 %id)
CB133447 Liver .b 772 to 1166 1 to 395       395/395
(100 %)
0 diff
(100 %id)
CB133451 Liver .b 772 to 1128 1 to 357       357/357
(100 %)
0 diff
(100 %id)
CB138621 Liver .b 772 to 1381 1 to 610       610/610
(100 %)
0 diff
(100 %id)
CB137200 Liver .b 772 to 902 1 to 132       132/132
(100 %)
1 diff
(99.3 %id)
CB137218 Liver .b 772 to 1291 11 to 530       520/530
(98 %)
6 diff
(98.9 %id)
BQ082817 stomach .b 772 to 905 1 to 134       134/134
(100 %)
0 diff
(100 %id)
BQ083988 stomach .b 772 to 1195 1 to 424       424/424
(100 %)
2 diff
(99.6 %id)
BM831107 stomach .b 772 to 1381 1 to 610       610/610
(100 %)
0 diff
(100 %id)
BM830939 stomach .b 772 to 1355 1 to 584       584/584
(100 %)
0 diff
(100 %id)
BM826875 stomach .b 772 to 1023 1 to 253       253/253
(100 %)
2 diff
(99.3 %id)
BM830729 stomach .b 772 to 1281 1 to 510       510/510
(100 %)
3 diff
(99.5 %id)
BF695345 muscle (skeletal) .b 773 to 1398 1 to 630       630/911
(69 %)
13 diff
(98.6 %id)
BF213778 bone marrow, from acute myelogenous leukemia .b 774 to 1300 1 to 527       527/527
(100 %)
1 diff
(99.9 %id)
BF693757 muscle (skeletal) .b 774 to 1490 1 to 712       712/884
(80 %)
14 diff
(98.5 %id)
BG250519 adenocarcinoma, cell line, Liver .b 774 to 1490 1 to 716       716/963
(74 %)
19 diff
(98.1 %id)
BG568075 Liver .b 774 to 1393 1 to 620       620/620
(100 %)
2 diff
(99.7 %id)
CB158414 Liver .b 774 to 1281 1 to 508       508/508
(100 %)
1 diff
(99.9 %id)
BC061637 Uterus, leiomyosarcoma .b 775 to 1686 1 to 912   available from MGC, AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 912/912
(100 %)
0 diff
(100 %id)
BP207890 coronary artery .b 775 to 1352 1 to 578       578/583
(99 %)
6 diff
(99.0 %id)
H91760 eye, retina .b 775 to 1063 1 to 290       290/294
(98 %)
8 diff
(97.3 %id)
AA448126   .b 775 to 1221 1 to 448       448/448
(100 %)
2 diff
(99.6 %id)
BI090468 cervix .b 775 to 1580 1 to 822       822/822
(100 %)
20 diff
(97.6 %id)
BM467880 leiomyosarcoma, uterus .b 775 to 1686 1 to 913   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 913/914
(99 %)
9 diff
(99.1 %id)
CR611802 HeLa cells Cot 25-normalized .b 776 to 1675 1 to 900       900/900
(100 %)
0 diff
(100 %id)
BX341448   .b 776 to 1675 1 to 899   fully sequenced,   899/899
(100 %)
3 diff
(99.7 %id)
BI755395 brain .b 776 to 1325 1 to 549       549/549
(100 %)
1 diff
(99.9 %id)
TI_57216918   .b 776 to 1325 36 to 584       549/584
(94 %)
6 diff
(99.0 %id)
BM824665 Ascites, stomach .b 776 to 1014 1 to 239       239/239
(100 %)
14 diff
(94.2 %id)
BM824886 Ascites, stomach .b 776 to 1480 1 to 705       705/705
(100 %)
0 diff
(100 %id)
TI_154189015   .b 776 to 1716 50 to 985       936/1027
(91 %)
27 diff
(97.4 %id)
D60004 brain .b 777 to 1238 1 to 462       462/462
(100 %)
1 diff
(99.8 %id)
D81471 brain .b 777 to 1061 1 to 283       283/283
(100 %)
2 diff
(99.3 %id)
D61327   .b 777 to 1203 1 to 426       426/426
(100 %)
3 diff
(99.3 %id)
D81800 brain .b 777 to 1015 1 to 239       239/239
(100 %)
3 diff
(98.8 %id)
R02703 liver and spleen .b 777 to 1161 1 to 395     Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 395/395
(100 %)
11 diff
(97.3 %id)
CF128872 Chondrosarcoma Lung Metastasis cell lines, lung .b 777 to 1537 1 to 761       761/761
(100 %)
2 diff
(99.8 %id)
CB124739 Liver .b 777 to 1280 1 to 504       504/504
(100 %)
2 diff
(99.7 %id)
CB160327 Liver .b 777 to 1269 1 to 493       493/493
(100 %)
1 diff
(99.8 %id)
H29248 whole brain .b 778 to 1220 1 to 452       452/510
(88 %)
10 diff
(98.1 %id)
BG249394 hypernephroma, cell line, Kidney .b 778 to 1535 1 to 746       746/933
(79 %)
35 diff
(96.3 %id)
BU557965 adenocarcinoma, cell line, breast .b 778 to 1657 1 to 882       882/909
(97 %)
19 diff
(98.0 %id)
BM819068 stomach .b 778 to 1178 1 to 402       402/402
(100 %)
16 diff
(96.1 %id)
AA310823   .b 779 to 1102 1 to 324       324/324
(100 %)
1 diff
(99.7 %id)
D81008 brain .b 779 to 984 1 to 206       206/206
(100 %)
0 diff
(100 %id)
BE379884 bladder, carcinoma, cell line .b 780 to 1317 1 to 527   fully sequenced,   527/527
(100 %)
3 diff
(99.5 %id)
BM782888 myeloma .b 780 to 1269 1 to 492       492/492
(100 %)
3 diff
(99.4 %id)
BE865543 bladder, carcinoma, cell line .b 781 to 1407 1 to 625       625/625
(100 %)
4 diff
(99.4 %id)
DN997964 breast cancer, Mammary gland (cancer tissue) .b 782 to 1458 9 to 684       676/684
(98 %)
7 diff
(99.0 %id)
R83398 liver and spleen .b 785 to 1258 1 to 492       492/495
(99 %)
27 diff
(94.6 %id)
AK000678 ileal mucosa .b 786 to 1799 1 to 1015   available from FLJ, AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 1015/1015
(100 %)
4 diff
(99.7 %id)
BP383391 ilea mucosa .b 786 to 1372 1 to 588       588/609
(96 %)
6 diff
(99.1 %id)
CN427690 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 787 to 1511 1 to 724       724/724
(100 %)
2 diff
(99.8 %id)
BE566854 bladder, carcinoma, cell line .b 788 to 1488 1 to 709       709/784
(90 %)
39 diff
(95.1 %id)
D82666   .b 790 to 1040 1 to 251       251/252
(99 %)
6 diff
(97.7 %id)
T48481   .b 790 to 1040 1 to 251       251/252
(99 %)
6 diff
(97.7 %id)
T48507   .b 790 to 1069 1 to 280       280/280
(100 %)
6 diff
(97.9 %id)
BX400252   .b 791 to 1762 972 to 1       972/972
(100 %)
8 diff
(99.2 %id)
BQ277214 mixed (pool of 40 RNAs) .b 791 to 1599 1 to 813       813/906
(89 %)
21 diff
(97.7 %id)
CF126524 Chondrosarcoma Lung Metastasis cell lines, lung .b 791 to 1504 11 to 723       713/723
(98 %)
8 diff
(98.9 %id)
TI_154189526   .b 791 to 1669 60 to 928       869/984
(88 %)
27 diff
(97.3 %id)
BF027733 bladder, carcinoma, cell line .b 792 to 1414 1 to 616       616/873
(70 %)
18 diff
(98.0 %id)
CB993126 placenta, pre-eclamptic placenta .b 792 to 1576 24 to 811       788/814
(96 %)
11 diff
(98.7 %id)
BI766677 pooled lung and spleen .b 793 to 1624 1 to 832       832/835
(99 %)
4 diff
(99.6 %id)
TI_57181259   .b 793 to 1624 71 to 902       832/905
(91 %)
10 diff
(98.9 %id)
CB147509 Liver .b 793 to 1381 1 to 589       589/589
(100 %)
1 diff
(99.9 %id)
AA173747   .b 794 to 1267 1 to 474       474/474
(100 %)
2 diff
(99.6 %id)
BG436434 placenta .b 794 to 1549 1 to 759       759/759
(100 %)
9 diff
(98.9 %id)
DA439021 tongue, tumor tissue .b 795 to 1388 2 to 595   capped   594/594
(100 %)
0 diff
(100 %id)
AV715074   .b 796 to 1567 1 to 768       768/772
(99 %)
15 diff
(98.1 %id)
DB453575 testis .b 796 to 1285 1 to 490       490/490
(100 %)
1 diff
(99.8 %id)
AA160105 Pancreas .b 796 to 1057 1 to 270   fully sequenced,   270/270
(100 %)
7 diff
(97.5 %id)
CB106323 Liver .b 796 to 966 1 to 171       171/172
(99 %)
2 diff
(98.9 %id)
BP336913 coronary artery .b 796 to 1377 1 to 582       582/582
(100 %)
0 diff
(100 %id)
CN427684 embryonic stem cells, DMSO-treated H9 cellline .b 797 to 1497 1 to 702       702/702
(100 %)
2 diff
(99.8 %id)
BE619033 large cell carcinoma, lung .b 798 to 1591 1 to 781       781/882
(88 %)
25 diff
(97.2 %id)
CF595643 Stomach, adenocarcinoma .b 798 to 1642 1 to 856       856/860
(99 %)
30 diff
(96.6 %id)
AA374748 lung .b 799 to 1124 1 to 326       326/326
(100 %)
1 diff
(99.7 %id)
BF218534 brain, glioblastoma .b 799 to 1466 1 to 664       664/707
(93 %)
19 diff
(97.4 %id)
BU191620 epidermoid carcinoma, cell line, salivary gland .b 799 to 1581 1 to 788       788/1000
(78 %)
30 diff
(97.0 %id)
AA372178 colon .b 801 to 1096 1 to 299       299/299
(100 %)
3 diff
(99.0 %id)
AW963589   .b 802 to 1553 1 to 753       753/753
(100 %)
5 diff
(99.4 %id)
R69927 placenta .b 802 to 1338 1 to 549   fully sequenced,   549/549
(100 %)
22 diff
(96.0 %id)
BU943103 mixed (pool of 40 RNAs) .b 803 to 1443 1 to 648       648/830
(78 %)
20 diff
(97.6 %id)
H54666 liver and spleen .b 804 to 1269 1 to 477       477/485
(98 %)
15 diff
(97.0 %id)
BE787970 large cell carcinoma, lung .b 804 to 1414 1 to 633       633/685
(92 %)
35 diff
(94.9 %id)
BP428522   .b 804 to 1148 1 to 345       345/345
(100 %)
1 diff
(99.8 %id)
CB158293 Liver .b 805 to 1167 1 to 363       363/363
(100 %)
1 diff
(99.8 %id)
BM545838 ovary (pool of 3) .b 806 to 1601 1 to 805       805/996
(80 %)
15 diff
(98.5 %id)
CR607655 T cells (Jurkat cell line) Cot10-normalized .b 809 to 1687 1 to 879       879/879
(100 %)
0 diff
(100 %id)
BX344385   .b 809 to 1687 1 to 879   fully sequenced,   879/879
(100 %)
4 diff
(99.6 %id)
R00751 liver and spleen .b 811 to 1184 1 to 388       388/393
(98 %)
18 diff
(95.5 %id)
W68502 heart .b 811 to 1334 1 to 527   fully sequenced, Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 527/527
(100 %)
3 diff
(99.5 %id)
AA147253 uterus .b 811 to 1277 1 to 468       468/468
(100 %)
6 diff
(98.8 %id)
CB121135 Liver .b 811 to 1286 1 to 476       476/476
(100 %)
0 diff
(100 %id)
CB158336 Liver .b 812 to 1459 10 to 657       648/657
(98 %)
6 diff
(99.1 %id)
BE886436 leiomyosarcoma, uterus .b 813 to 1301 1 to 489       489/489
(100 %)
0 diff
(100 %id)
TI_59382365   .b 814 to 1559 117 to 862       746/751
(99 %)
9 diff
(98.9 %id)
BC009645 Cervix, carcinoma .b 815 to 3649 1 to 2835   tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 2835/2835
(100 %)
4 diff
(99.9 %id)
AA043053 uterus .b 815 to 1310 1 to 501   fully sequenced,   501/501
(100 %)
5 diff
(99.1 %id)
BU571017 brain, glioblastoma .b 815 to 1649 1 to 838       838/838
(100 %)
21 diff
(97.5 %id)
BU571022 brain, glioblastoma .b 815 to 1601 1 to 791       791/807
(98 %)
40 diff
(95.1 %id)
BU928279 brain, glioblastoma .b 815 to 1486 1 to 677       677/814
(83 %)
13 diff
(98.5 %id)
NM_017924.2   .b 815 to 3649 1 to 2835   RefSeq, AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 2835/2835
(100 %)
4 diff
(99.9 %id)
BE564664 bladder, carcinoma, cell line .b 816 to 1456 1 to 649       649/649
(100 %)
26 diff
(96.0 %id)
AA306641   .b 820 to 1295 1 to 470       470/471
(99 %)
8 diff
(98.4 %id)
AA088798 colon, tumor .b 821 to 1195 1 to 381       381/381
(100 %)
7 diff
(98.2 %id)
AA373880 lung .b 822 to 1124 1 to 303       303/303
(100 %)
0 diff
(100 %id)
CU445074 epidermis .b 824 to 1632 8 to 817       810/817
(99 %)
9 diff
(98.9 %id)
CU450813 epidermis .b 824 to 1603 8 to 788       781/788
(99 %)
7 diff
(99.2 %id)
BX344384   .b 825 to 1656 832 to 1   fully sequenced,   832/832
(100 %)
7 diff
(99.2 %id)
BX341447   .b 825 to 1644 822 to 1   fully sequenced,   822/822
(100 %)
21 diff
(97.5 %id)
AA370277 Prostate .b 826 to 1170 1 to 348       348/349
(99 %)
7 diff
(98.0 %id)
CN427688 embryonic stem cells, DMSO-treated H9 cellline .b 826 to 1365 1 to 540       540/540
(100 %)
1 diff
(99.9 %id)
AA290823 ovarian tumor, ovary .b 830 to 1107 1 to 279       279/279
(100 %)
6 diff
(97.9 %id)
BE545856 cervical carcinoma cell line, cervix .b 835 to 1503 1 to 673   AAA   673/801
(84 %)
8 diff
(99.1 %id)
CN427683 embryonic stem cells, DMSO-treated H9 cellline .b 845 to 1343 1 to 499       499/499
(100 %)
0 diff
(100 %id)
BM700437 eye, lens .b 854 to 1293 1 to 440   fully sequenced, Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 440/440
(100 %)
0 diff
(100 %id)
AA165689 Pancreas .b 1027 to 1686 650 to 1   fully sequenced,   650/650
(100 %)
13 diff
(98.0 %id)
BM670550 eye, lens .b 1263 to 1799 555 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 537/537
(100 %)
1 diff
(99.9 %id)
D80509 brain .b 1272 to 1692 422 to 1       422/422
(100 %)
2 diff
(99.6 %id)
BE379804 bladder, carcinoma, cell line .b 1287 to 1748 458 to 1   fully sequenced,   458/458
(100 %)
9 diff
(98.1 %id)
R02584 liver and spleen .b 1292 to 1686 422 to 14   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 409/427
(95 %)
15 diff
(96.5 %id)
H54667 liver and spleen .b 1292 to 1683 400 to 1       400/403
(99 %)
9 diff
(97.8 %id)
AA155747 uterus .b 1302 to 1797 493 to 3       491/494
(99 %)
0 diff
(100 %id)
W68386 heart .b 1304 to 1686 412 to 20   fully sequenced, AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 393/393
(100 %)
12 diff
(97.0 %id)
AA044419 uterus .b 1306 to 1797 500 to 7   fully sequenced,   494/500
(98 %)
0 diff
(100 %id)
AA284937 ovarian tumor, ovary .b 1306 to 1687 386 to 5       382/386
(98 %)
0 diff
(100 %id)
R69879 placenta .b 1308 to 1665 367 to 1   fully sequenced,   367/367
(100 %)
10 diff
(97.3 %id)
H73552 liver and spleen .b 1345 to 1795 466 to 2       465/506
(91 %)
0 diff
(100 %id)
AA447984   .b 1379 to 1797 424 to 6       419/424
(98 %)
0 diff
(100 %id)
H29249 whole brain .b 1387 to 1800 426 to 8       419/429
(97 %)
0 diff
(100 %id)
AA172386   .b 1596 to 1797 203 to 2       202/203
(99 %)
0 diff
(100 %id)
BU853657 testis .c-u 1 to 750 1 to 755   tiling clone,   755/837
(90 %)
30 diff
(96.5 %id)
BG291795 bladder, transitional cell papilloma, cell line .c-u 141 to 645 1 to 501       501/852
(58 %)
5 diff
(99.5 %id)
BG167661 hypernephroma, cell line, Kidney .c-u 214 to 883 1 to 657       657/931
(70 %)
19 diff
(98.0 %id)
CX872252 embryonic stem .c-u 411 to 1252 1 to 839   tiling clone,   839/839
(100 %)
1 diff
(99.9 %id)
AW371956 breast .c-u 617 to 1054 1 to 438       438/438
(100 %)
18 diff
(95.9 %id)
CN427685 embryonic stem cells, DMSO-treated H9 cellline .c-u 670 to 1204 1 to 535       535/535
(100 %)
2 diff
(99.7 %id)
BQ130201 insulinoma, Pancreas .c-u 947 to 1382 2 to 437 K64N fully sequenced,   436/437
(99 %)
6 diff
(98.7 %id)
BU071570 insulinoma, Pancreas .c-u 947 to 1469 2 to 524 exact fully sequenced,   523/524
(99 %)
5 diff
(99.1 %id)
BE712885 head_neck .c-u 949 to 1356 12 to 418       407/418
(97 %)
6 diff
(98.6 %id)
BE713006 head_neck .c-u 949 to 1327 12 to 390       379/390
(97 %)
6 diff
(98.5 %id)
BE825184 colon_normal .c-u 949 to 1289 55 to 393       339/594
(57 %)
7 diff
(98.9 %id)
AA189005   .c-u 949 to 1147 10 to 211       202/211
(95 %)
5 diff
(97.7 %id)
BM800623 leiomyosarcoma, uterus .c-u 949 to 1805 28 to 891 exact     864/1065
(81 %)
13 diff
(98.8 %id)
CR457248   .c-u 952 to 1370 1 to 419       419/423
(99 %)
1 diff
(99.8 %id)
H04568 placenta .c-u 952 to 1442 1 to 483 F13S P14H S15L Q37R E38R ... fully sequenced,   483/483
(100 %)
10 diff
(98.0 %id)
BQ270688 insulinoma, Pancreas .c-u 953 to 1501 8 to 556       549/556
(98 %)
6 diff
(99.0 %id)
CK825326 insulinoma, Pancreas .c-u 953 to 1505 8 to 560       553/560
(98 %)
6 diff
(99.0 %id)
TI_154122983   .c-u 955 to 1781 913 to 92   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 822/957
(85 %)
11 diff
(98.9 %id)
BX330704 Placenta Cot 25-normalized .c-u 957 to 1778 823 to 1       823/823
(100 %)
16 diff
(98.1 %id)
BE619691 large cell carcinoma, lung .c-u 960 to 1729 776 to 1       776/776
(100 %)
16 diff
(98.0 %id)
TI_154115242   .c-u 991 to 1781 877 to 94   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 784/937
(83 %)
17 diff
(98.2 %id)
FN106666 breast carcinoma .c-u 992 to 1059 1 to 69       69/69
(100 %)
1 diff
(98.6 %id)
TI_149300508   .c-u 1001 to 1781 858 to 84   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 775/931
(83 %)
16 diff
(98.3 %id)
BE811228 amnion_normal .c-u 1003 to 1349 1 to 350       350/350
(100 %)
9 diff
(97.5 %id)
BQ277045 mixed (pool of 40 RNAs) .c-u 1008 to 1782 1 to 781       781/834
(93 %)
17 diff
(98.0 %id)
BE811205 amnion_normal .c-u 1010 to 1327 9 to 326       318/326
(97 %)
6 diff
(98.2 %id)
BE811252 amnion_normal .c-u 1010 to 1313 10 to 317       308/317
(97 %)
6 diff
(98.2 %id)
BE811208 amnion_normal .c-u 1012 to 1163 15 to 166       152/166
(91 %)
6 diff
(96.4 %id)
TI_154131906   .c-u 1015 to 1781 853 to 90   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 764/951
(80 %)
14 diff
(98.6 %id)
BE811264 amnion_normal .c-u 1023 to 1310 1 to 288       288/288
(100 %)
1 diff
(99.7 %id)
BE811266 amnion_normal .c-u 1023 to 1164 1 to 142       142/142
(100 %)
0 diff
(100 %id)
W68835 heart .c-u 1042 to 1659 1 to 615       615/615
(100 %)
9 diff
(98.6 %id)
TI_57175153   .c-u 1045 to 1768 30 to 754       725/754
(96 %)
6 diff
(99.3 %id)
BI828385 brain, medulla .c-u 1046 to 1767 1 to 724       724/724
(100 %)
2 diff
(99.8 %id)
BM743494 Ascites, stomach .c-u 1046 to 1439 1 to 397       397/397
(100 %)
11 diff
(97.3 %id)
BM743315 Ascites, stomach .c-u 1046 to 1598 1 to 553       553/553
(100 %)
1 diff
(99.9 %id)
BM784883 Ascites, stomach .c-u 1046 to 1424 1 to 379       379/379
(100 %)
0 diff
(100 %id)
BM766338 Ascites, stomach .c-u 1046 to 1601 1 to 556       556/556
(100 %)
5 diff
(99.2 %id)
BM748897 Ascites, stomach .c-u 1046 to 1181 1 to 136       136/136
(100 %)
2 diff
(98.6 %id)
BM748252 Ascites, stomach .c-u 1046 to 1635 1 to 591       591/591
(100 %)
3 diff
(99.5 %id)
BM757701 Ascites, stomach .c-u 1046 to 1699 1 to 654       654/654
(100 %)
1 diff
(99.9 %id)
BM757614 Ascites, stomach .c-u 1046 to 1723 1 to 678       678/678
(100 %)
1 diff
(99.9 %id)
CA390847 eye, RPE/choroid .c-u 1051 to 1631 1 to 581       581/581
(100 %)
0 diff
(100 %id)
CA310196 Alveolar Macrophage, lung .c-u 1056 to 1781 743 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 725/725
(100 %)
1 diff
(99.9 %id)
BE075014 breast .c-u 1060 to 1559 1 to 502       502/502
(100 %)
14 diff
(97.3 %id)
BG571879 placenta .c-u 1065 to 1677 269 to 891       623/892
(69 %)
25 diff
(97.2 %id)
TI_149292858   .c-u 1077 to 1781 787 to 83   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 705/705
(100 %)
6 diff
(99.2 %id)
BM976562 lung, Primary Lung Cystic Fibrosis EpithelialCells .c-u 1077 to 1781 723 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 705/707
(99 %)
4 diff
(99.5 %id)
CA443935 Fibrosarcoma .c-u 1077 to 1781 723 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 705/707
(99 %)
2 diff
(99.8 %id)
CR611338 Neuroblastoma Cot 50-normalized .c-u 1079 to 2396 1 to 1318   tiling clone,   1318/1318
(100 %)
0 diff
(100 %id)
BE546427 cervical carcinoma cell line, cervix .c-u 1085 to 1773 1 to 691       691/695
(99 %)
18 diff
(97.5 %id)
BX376893 Neuroblastoma Cot 50-normalized .c-u 1088 to 1748 10 to 656   fully sequenced,   647/656
(98 %)
0 diff
(100 %id)
BE747254 adenocarcinoma cell line, ovary .c-u 1091 to 1871 1 to 776       776/882
(87 %)
16 diff
(98.2 %id)
CA432108 cell lines, Enchondroma .c-u 1091 to 1781 710 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 692/692
(100 %)
1 diff
(99.9 %id)
W32147 parathyroid gland, parathyroid tumor .c-u 1092 to 1533 1 to 448   fully sequenced,   448/448
(100 %)
11 diff
(97.6 %id)
BQ014061 Chondrosarcoma, Left Pubic Bone .c-u 1092 to 1781 708 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 690/690
(100 %)
1 diff
(99.9 %id)
CA418338 Bone, Human Chondrosarcoma Cell Line .c-u 1092 to 1781 710 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 692/692
(100 %)
3 diff
(99.6 %id)
BU534925 mixed (pool of 40 RNAs) .c-u 1094 to 1781 1 to 689       689/694
(99 %)
6 diff
(99.2 %id)
BM700822 eye, human retina .c-u 1105 to 1580 1 to 476   fully sequenced, Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 476/476
(100 %)
5 diff
(99.0 %id)
BU624004 cell lines, Enchondroma .c-u 1105 to 1781 696 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 678/678
(100 %)
1 diff
(99.9 %id)
BM703160 eye, human retina .c-u 1113 to 1496 1 to 384   fully sequenced, Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 384/384
(100 %)
0 diff
(100 %id)
BM856150 stomach .c-u 1124 to 1391 1 to 268       268/268
(100 %)
2 diff
(99.3 %id)
BF373395 prostate_tumor .c-u 1134 to 1598 76 to 543       468/543
(86 %)
6 diff
(98.9 %id)
BQ931466 eye, normal pigmented retinal epithelium .c-u 1156 to 1781 1 to 625   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 625/625
(100 %)
2 diff
(99.7 %id)
BE695840 colon .c-u 1160 to 1542 1 to 383       383/383
(100 %)
5 diff
(98.7 %id)
BM743470 Ascites, stomach .c-u 1162 to 1556 1 to 395       395/395
(100 %)
1 diff
(99.8 %id)
CA309680 Alveolar Macrophage, lung .c-u 1170 to 1781 630 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 612/612
(100 %)
1 diff
(99.9 %id)
CK825325 insulinoma, Pancreas .c-u 1171 to 1782 618 to 7       612/618
(99 %)
0 diff
(100 %id)
FN082728 breast carcinoma .c-u 1185 to 1271 1 to 83       83/83
(100 %)
6 diff
(92.8 %id)
H90468 liver and spleen .c-u 1189 to 1641 1 to 464       464/465
(99 %)
13 diff
(97.3 %id)
AV714535   .c-u 1194 to 1542 174 to 523       435/523
(83 %)
40 diff
(92.4 %id)
TI_154033305   .c-u 1195 to 1906 831 to 127       705/995
(70 %)
0 diff
(100 %id)
CN427687 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c-u 1197 to 1590 1 to 394       394/394
(100 %)
1 diff
(99.8 %id)
BM974912 lung .c-u 1198 to 1781 602 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 584/584
(100 %)
0 diff
(100 %id)
FN113380 breast carcinoma .c-u 1214 to 1303 1 to 93       93/93
(100 %)
4 diff
(95.7 %id)
BQ270447 insulinoma, Pancreas .c-u 1221 to 1782 568 to 7       562/568
(98 %)
0 diff
(100 %id)
BQ018042 Fibrosarcoma .c-u 1222 to 1891 690 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 672/672
(100 %)
4 diff
(99.5 %id)
CD368981 Alveolar Macrophage, lung .c-u 1233 to 1891 677 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 659/659
(100 %)
3 diff
(99.6 %id)
W76163 heart .c-u 1235 to 1529 1 to 296   fully sequenced,   296/296
(100 %)
0 diff
(100 %id)
FN104672 breast carcinoma .c-u 1238 to 1330 1 to 99       99/99
(100 %)
10 diff
(89.9 %id)
CR595757 T cells (Jurkat cell line) .c-u 1241 to 1874 1 to 634       634/634
(100 %)
0 diff
(100 %id)
BX407938 T cells (Jurkat cell line) .c-u 1244 to 1894 651 to 1       651/651
(100 %)
12 diff
(98.2 %id)
BX407939 T cells (Jurkat cell line) .c-u 1244 to 1906 1 to 663       663/663
(100 %)
1 diff
(99.9 %id)
BX421804 T cells (Jurkat cell line) .c-u 1244 to 1906 1 to 663       663/663
(100 %)
1 diff
(99.9 %id)
BX453330 T cells (Jurkat cell line) .c-u 1244 to 1906 663 to 1       663/666
(99 %)
8 diff
(98.8 %id)
BX453331 T cells (Jurkat cell line) .c-u 1244 to 1874 632 to 1       632/632
(100 %)
8 diff
(98.8 %id)
BX453332 T cells (Jurkat cell line) .c-u 1244 to 1906 1 to 663       663/663
(100 %)
1 diff
(99.9 %id)
BX453333 T cells (Jurkat cell line) .c-u 1244 to 1900 1 to 658       658/666
(98 %)
4 diff
(99.4 %id)
BX456024 T cells (Jurkat cell line) .c-u 1244 to 1876 632 to 1       632/632
(100 %)
15 diff
(97.7 %id)
BX411027 T cells (Jurkat cell line) .c-u 1244 to 1906 662 to 1       662/662
(100 %)
17 diff
(97.5 %id)
BX411028 T cells (Jurkat cell line) .c-u 1244 to 1874 631 to 1       631/631
(100 %)
1 diff
(99.9 %id)
BX411029 T cells (Jurkat cell line) .c-u 1244 to 1906 1 to 663       663/663
(100 %)
1 diff
(99.9 %id)
BX411030 T cells (Jurkat cell line) .c-u 1244 to 1767 1 to 525       525/587
(89 %)
54 diff
(90.9 %id)
CR618010 HeLa cells Cot 25-normalized .c-u 1247 to 1892 1 to 646       646/646
(100 %)
0 diff
(100 %id)
BX363369   .c-u 1249 to 1892 1 to 644   fully sequenced,   644/644
(100 %)
5 diff
(99.3 %id)
W45660 senescent fibroblast .c-u 1253 to 1434 1 to 182   fully sequenced,   182/182
(100 %)
1 diff
(99.5 %id)
AA043585 uterus .c-u 1257 to 1598 1 to 350   fully sequenced,   350/350
(100 %)
1 diff
(99.8 %id)
FN177690 breast carcinoma .c-u 1265 to 1330 1 to 65       65/65
(100 %)
3 diff
(95.4 %id)
FN159104 breast carcinoma .c-u 1267 to 1358 1 to 90       90/90
(100 %)
2 diff
(97.8 %id)
TI_59391779   .c-u 1268 to 1781 55 to 569   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 515/515
(100 %)
1 diff
(99.9 %id)
BM013842 breast, mammary adenocarcinoma, cell line .c-u 1269 to 1781 1 to 514   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 514/514
(100 %)
1 diff
(99.9 %id)
BP390090 pancreatic islet .c-u 1278 to 1778 1 to 501     Submitted on the opposite strand 501/502
(99 %)
1 diff
(99.9 %id)
CA444366 Fibrosarcoma .c-u 1281 to 1891 628 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 610/610
(100 %)
4 diff
(99.4 %id)
AA843801 parathyroid gland, parathyroid tumor .c-u 1290 to 1781 504 to 13   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 492/492
(100 %)
1 diff
(99.8 %id)
BQ356286 head_neck .c-u 1293 to 1777 1 to 485       485/485
(100 %)
11 diff
(97.8 %id)
AW580266 head_neck .c-u 1310 to 1622 1 to 314       314/314
(100 %)
4 diff
(98.8 %id)
N31735.
matches multiple genes
melanocyte .c-u 1313 to 1939 624 to 1     also hits gene SGOL2 624/624
(100 %)
13 diff
(98.0 %id)
N83795   .c-u 1313 to 1467 1 to 154       154/154
(100 %)
2 diff
(98.8 %id)
DB548158 hippocampus .c-u 1318 to 1785 1 to 468     Submitted on the opposite strand 468/470
(99 %)
1 diff
(99.8 %id)
DB526467 testis .c-u 1329 to 1781 1 to 453     Submitted on the opposite strand 453/453
(100 %)
0 diff
(100 %id)
AI370791   .c-u 1329 to 1782 457 to 4       454/457
(99 %)
0 diff
(100 %id)
BQ020623 Fibrosarcoma .c-u 1330 to 1939 627 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 609/609
(100 %)
4 diff
(99.4 %id)
BF348924 denis_drash .c-u 1333 to 1695 1 to 365       365/365
(100 %)
13 diff
(96.5 %id)
CV314028 denis_drash .c-u 1341 to 1808 1 to 476       476/476
(100 %)
31 diff
(93.5 %id)
H97869 melanocyte .c-u 1344 to 1893 555 to 1       555/556
(99 %)
12 diff
(97.9 %id)
AW938169 denis_drash .c-u 1345 to 1695 12 to 361       350/361
(96 %)
6 diff
(98.4 %id)
BM547675 brain, hippocampus .c-u 1345 to 1782 1 to 436       436/517
(84 %)
4 diff
(99.3 %id)
BQ322594 colon_est .c-u 1350 to 1601 1 to 252       252/252
(100 %)
1 diff
(99.7 %id)
BQ129950 insulinoma, Pancreas .c-u 1352 to 1763 412 to 1   fully sequenced,   412/412
(100 %)
3 diff
(99.3 %id)
AA676807 liver and spleen .c-u 1361 to 1781 422 to 1       422/422
(100 %)
3 diff
(99.3 %id)
CV314030 denis_drash .c-u 1363 to 1695 44 to 376       333/376
(88 %)
6 diff
(98.5 %id)
BE000504 breast_normal .c-u 1374 to 1597 1 to 222       222/232
(95 %)
7 diff
(97.0 %id)
FN111962 breast carcinoma .c-u 1376 to 1450 1 to 77       77/84
(91 %)
3 diff
(96.5 %id)
BP298120   .c-u 1380 to 1781 1 to 402   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 402/402
(100 %)
3 diff
(99.3 %id)
BP298472   .c-u 1380 to 1782 1 to 405       405/582
(69 %)
5 diff
(99.2 %id)
AW798937 uterus .c-u 1382 to 1573 1 to 187       187/219
(85 %)
10 diff
(95.5 %id)
D60663.
matches multiple genes
brain .c-u 1382 to 1787 405 to 1     also hits gene BTBD9 405/405
(100 %)
5 diff
(98.8 %id)
AA917460 pooled .c-u 1382 to 1782 402 to 2       401/402
(99 %)
0 diff
(100 %id)
AA513086 Ewing's sarcoma .c-u 1383 to 1782 1 to 400       400/402
(99 %)
6 diff
(98.6 %id)
AW798968 uterus .c-u 1384 to 1564 1 to 179       179/179
(100 %)
4 diff
(97.8 %id)
BE000575 breast_normal .c-u 1385 to 1597 1 to 211       211/226
(93 %)
4 diff
(98.3 %id)
TI_157614272   .c-u 1387 to 1881 600 to 106   AAA   495/505
(98 %)
0 diff
(100 %id)
AW938168 denis_drash .c-u 1394 to 1695 56 to 360       305/360
(84 %)
6 diff
(98.4 %id)
AA668796 germinal center B cell .c-u 1395 to 1891 510 to 14   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 497/497
(100 %)
1 diff
(99.8 %id)
AW474571 serous papillary carcinoma, high grade, 2pooled tumors, uterus .c-u 1398 to 1895 504 to 7       498/504
(98 %)
0 diff
(100 %id)
BF000114 colon, colon tumor, RER+ .c-u 1401 to 1891 491 to 1       491/491
(100 %)
2 diff
(99.6 %id)
W44313 senescent fibroblast .c-u 1404 to 1896 499 to 1   fully sequenced,   499/499
(100 %)
10 diff
(98.0 %id)
BU161296 melanotic melanoma, skin .c-u 1405 to 1891 1 to 487       487/947
(51 %)
2 diff
(99.8 %id)
H13156 placenta .c-u 1412 to 1747 351 to 1   fully sequenced,   351/351
(100 %)
17 diff
(95.2 %id)
H41216 liver and spleen .c-u 1415 to 1893 484 to 1       484/487
(99 %)
13 diff
(97.4 %id)
AI337864 uterus .c-u 1416 to 1891 476 to 1       476/476
(100 %)
1 diff
(99.8 %id)
DB519037 testis .c-u 1423 to 1891 1 to 469     Submitted on the opposite strand 469/469
(100 %)
0 diff
(100 %id)
AI819127 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .c-u 1426 to 1891 501 to 35   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 467/467
(100 %)
9 diff
(98.1 %id)
AI582827 anaplastic oligodendroglioma, brain .c-u 1428 to 1767 379 to 40   AAA   340/349
(97 %)
0 diff
(100 %id)
BM991356 lung, Metastatic Chondrosarcoma .c-u 1429 to 1781 371 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 353/353
(100 %)
0 diff
(100 %id)
AA709464 pineal gland .c-u 1433 to 1901 472 to 4       469/472
(99 %)
0 diff
(100 %id)
AA780333   .c-u 1434 to 1893 465 to 7       459/465
(98 %)
0 diff
(100 %id)
DB563797 hypothalamus .c-u 1436 to 1889 1 to 456     Submitted on the opposite strand 456/458
(99 %)
4 diff
(99.2 %id)
BU071340 insulinoma, Pancreas .c-u 1439 to 1788 350 to 1   fully sequenced,   350/350
(100 %)
5 diff
(98.6 %id)
AI368738   .c-u 1443 to 1782 348 to 9       340/348
(97 %)
0 diff
(100 %id)
AI423470 brain, glioblastoma (pooled) .c-u 1444 to 1895 452 to 1       452/452
(100 %)
1 diff
(99.8 %id)
DB542771 hippocampus .c-u 1446 to 1891 1 to 446     Submitted on the opposite strand 446/446
(100 %)
2 diff
(99.6 %id)
AA047593 heart .c-u 1446 to 1890 1 to 448   fully sequenced,   448/448
(100 %)
5 diff
(98.9 %id)
DB562148 hypothalamus .c-u 1447 to 1889 1 to 443     Submitted on the opposite strand 443/445
(99 %)
2 diff
(99.6 %id)
BG057667 blood, lymphocyte .c-u 1451 to 1892 444 to 3       442/444
(99 %)
0 diff
(100 %id)
AA643662 colon, colon tumor RER+ .c-u 1453 to 1782 330 to 1       330/330
(100 %)
1 diff
(99.7 %id)
AA035740 heart .c-u 1454 to 1651 1 to 198       198/198
(100 %)
0 diff
(100 %id)
W57760 heart .c-u 1455 to 1891 1 to 439   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 439/439
(100 %)
4 diff
(99.1 %id)
AA868403   .c-u 1455 to 1892 440 to 3       438/440
(99 %)
0 diff
(100 %id)
AI208092   .c-u 1460 to 1782 325 to 3       323/325
(99 %)
0 diff
(100 %id)
BF378612 uterus .c-u 1462 to 1589 17 to 145       129/147
(87 %)
6 diff
(96.0 %id)
FN132275 breast carcinoma .c-u 1463 to 1562 1 to 101       101/101
(100 %)
1 diff
(99.1 %id)
BM664659 eye, human retina .c-u 1466 to 1894 447 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 429/429
(100 %)
1 diff
(99.8 %id)
AA514685 colon .c-u 1468 to 1781 329 to 16   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 314/314
(100 %)
0 diff
(100 %id)
AA768005 germinal center B cell .c-u 1468 to 1891 437 to 14   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 424/424
(100 %)
1 diff
(99.8 %id)
AI335693 uterus .c-u 1471 to 1895 426 to 2       425/426
(99 %)
0 diff
(100 %id)
AI362043 brain, glioblastoma (pooled) .c-u 1471 to 1895 425 to 1       425/425
(100 %)
1 diff
(99.8 %id)
T32428 Spleen .c-u 1472 to 1776 305 to 1       305/305
(100 %)
0 diff
(100 %id)
DB559098 hypothalamus .c-u 1477 to 1891 1 to 415     Submitted on the opposite strand 415/415
(100 %)
1 diff
(99.8 %id)
DB563014 hypothalamus .c-u 1477 to 1889 1 to 413     Submitted on the opposite strand 413/415
(99 %)
2 diff
(99.6 %id)
N51232 multiple sclerosis lesions .c-u 1478 to 1934 458 to 1       458/458
(100 %)
1 diff
(99.8 %id)
DB538058 hippocampus .c-u 1479 to 1893 1 to 414     Submitted on the opposite strand 414/414
(100 %)
6 diff
(98.6 %id)
AI264595 Kidney .c-u 1486 to 1891 406 to 1       406/406
(100 %)
1 diff
(99.8 %id)
AA633653   .c-u 1492 to 1859 368 to 1       368/368
(100 %)
1 diff
(99.8 %id)
AA189006   .c-u 1494 to 1890 397 to 1       397/397
(100 %)
1 diff
(99.8 %id)
AW449694   .c-u 1498 to 1934 454 to 18   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 437/437
(100 %)
5 diff
(98.9 %id)
W72538 heart .c-u 1499 to 1906 413 to 1   fully sequenced,   413/413
(100 %)
2 diff
(99.6 %id)
CF528334 placenta .c-u 1504 to 1891 406 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 388/389
(99 %)
0 diff
(100 %id)
AW449533   .c-u 1508 to 1781 292 to 18   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 275/275
(100 %)
12 diff
(95.7 %id)
DV459025 cochlea, ear .c-u 1508 to 1876 1 to 371   AAA   371/379
(97 %)
7 diff
(98.2 %id)
W32175 parathyroid gland, parathyroid tumor .c-u 1509 to 1891 392 to 1   fully sequenced,   392/392
(100 %)
12 diff
(97.0 %id)
AW938167 denis_drash .c-u 1519 to 1808 1 to 291       291/291
(100 %)
8 diff
(97.3 %id)
BM773059 Ascites, stomach .c-u 1528 to 1938 1 to 411       411/411
(100 %)
1 diff
(99.8 %id)
AA768358 germinal center B cell .c-u 1547 to 1891 358 to 14   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 345/345
(100 %)
1 diff
(99.8 %id)
BM672190 eye, human retina .c-u 1550 to 1894 363 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 345/345
(100 %)
3 diff
(99.2 %id)
AI970743 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .c-u 1551 to 1892 343 to 2       342/343
(99 %)
0 diff
(100 %id)
AA887459 Kidney .c-u 1552 to 1782 239 to 9       231/242
(95 %)
0 diff
(100 %id)
AA516406 colon .c-u 1554 to 1939 406 to 21   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 386/386
(100 %)
1 diff
(99.8 %id)
AW879676 ovary .c-u 1556 to 1665 1 to 106       106/112
(94 %)
9 diff
(92.0 %id)
T16671   .c-u 1557 to 1894 338 to 1       338/338
(100 %)
1 diff
(99.8 %id)
AA043246 uterus .c-u 1568 to 1894 329 to 1   fully sequenced,   329/329
(100 %)
2 diff
(99.4 %id)
AI243028 liver and spleen .c-u 1578 to 1891 314 to 1       314/314
(100 %)
2 diff
(99.4 %id)
AI370304 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .c-u 1578 to 1893 318 to 3       316/318
(99 %)
0 diff
(100 %id)
AI659832 Prostate .c-u 1578 to 1892 320 to 6       315/320
(98 %)
0 diff
(100 %id)
AA471066 colon .c-u 1585 to 1892 313 to 5       309/313
(98 %)
0 diff
(100 %id)
FN081624 breast carcinoma .c-u 1596 to 1677 1 to 81       81/85
(95 %)
4 diff
(95.3 %id)
AA635861 normal prostate, Prostate .c-u 1600 to 1892 298 to 6       293/298
(98 %)
0 diff
(100 %id)
AA977176 pooled germ cell tumors .c-u 1610 to 1893 303 to 20   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 284/284
(100 %)
1 diff
(99.7 %id)
CB125896 Liver .c-u 1610 to 1900 1 to 293   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 293/293
(100 %)
4 diff
(98.7 %id)
BU675756 lung, Primary Lung Epithelial Cells .c-u 1627 to 1891 276 to 12   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 265/273
(97 %)
1 diff
(99.7 %id)
BM968876 lung, Primary Lung Epithelial Cells .c-u 1627 to 1891 276 to 12   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 265/273
(97 %)
1 diff
(99.7 %id)
T17177   .c-u 1640 to 1932 294 to 1       294/294
(100 %)
2 diff
(99.4 %id)
AA047601 heart .c-u 1666 to 1891 226 to 1   fully sequenced,   226/226
(100 %)
1 diff
(99.6 %id)
FN117736 breast carcinoma .c-u 1672 to 1779 1 to 111       111/114
(97 %)
4 diff
(96.5 %id)
AW368729 head_neck .c-u 1682 to 1837 1 to 156       156/156
(100 %)
2 diff
(98.8 %id)
FN046541 breast carcinoma .c-u 1692 to 1758 1 to 66       66/67
(98 %)
2 diff
(97.1 %id)
AI718437 aorta .c-u 1700 to 1884 185 to 1       185/185
(100 %)
1 diff
(99.5 %id)
BE811210 amnion_normal .c-u 1705 to 1838 1 to 136       136/148
(91 %)
6 diff
(96.0 %id)
BX376892 Neuroblastoma Cot 50-normalized .c-u 1718 to 2396 671 to 1   fully sequenced,   671/671
(100 %)
30 diff
(95.6 %id)
T17166   .c-u 1746 to 1932 187 to 1       187/187
(100 %)
1 diff
(99.5 %id)
N31729.
matches multiple genes
melanocyte .c-u 1763 to 1939 177 to 1     also hits gene SNRPC 177/188
(94 %)
0 diff
(100 %id)
FN109946 breast carcinoma .c-u 1787 to 1884 1 to 98       98/98
(100 %)
1 diff
(99.0 %id)
BX363368   .c-u 1817 to 1858 42 to 1   fully sequenced,   42/42
(100 %)
0 diff
(100 %id)
BF033443 adenocarcinoma, ovary .c-u 1836 to 1934 1 to 99       99/99
(100 %)
1 diff
(99.0 %id)
AA779858   .c-u 1966 to 2236 1 to 272     Submitted on the opposite strand 272/272
(100 %)
5 diff
(98.2 %id)
BF943444 nervous_normal .c-u 3070 to 3389 19 to 338   tiling clone,   320/343
(93 %)
5 diff
(98.6 %id)
AW991508 breast_normal .c-u 3075 to 3202 149 to 24   tiling clone, Submitted on the opposite strand 126/149
(84 %)
0 diff
(100 %id)
BU521289 leiomyosarcoma, uterus .c-u 3090 to 3744 684 to 24   tiling clone, AAA Submitted on the opposite strand 661/883
(74 %)
24 diff
(97.3 %id)
CA453774 mixed (pool of 40 RNAs) .d 1 to 641 5 to 651 S12G tiling clone,   651/889
(73 %)
23 diff
(97.5 %id)
BG493005 lung, mucoepidermoid carcinoma .d 4 to 789 1 to 791   tiling clone,   791/791
(100 %)
57 diff
(92.8 %id)
BF030507 hypernephroma, Kidney .d 49 to 716 1 to 658   tiling clone,   658/884
(74 %)
19 diff
(97.9 %id)
AV704772 adrenal gland Gene C14orf119, variant not shown         This clone was ignored    
AV705626 adrenal gland Gene C14orf119, variant not shown         This clone was ignored    
AV707417 adrenal gland Gene C14orf119, variant not shown         This clone was ignored    
AW381474 head_neck Gene C14orf119, variant not shown         This clone was ignored    
CD695708 normal nasopharynx Gene C14orf119, variant not shown         Suspected internal deletion, this clone was ignored    
AV710648 adrenal cortico adenoma for Cushing'ssyndrome Gene C14orf119, variant not shown         This clone was ignored    
AV716086   Gene C14orf119, variant not shown         This clone was ignored    
AV715101   Gene C14orf119, variant not shown         This clone was ignored    
AV717351   Gene C14orf119, variant not shown         This clone was ignored    
AV717930   Gene C14orf119, variant not shown         This clone was ignored    
AA436869   Gene C14orf119, variant not shown         Suspected internal deletion, this clone was ignored    
AA442627   Gene C14orf119, variant not shown         Suspected internal deletion, this clone was ignored    
AA903149 leiomyosarcoma, soft tissue Gene C14orf119, variant not shown         Suspected internal deletion, this clone was ignored    
AW183083 pooled Gene C14orf119, variant not shown         Suspected internal deletion, this clone was ignored    
AW236990 pooled germ cell tumors Gene C14orf119, variant not shown         Suspected internal deletion, this clone was ignored    
BF432475 brain, glioblastoma (pooled) Gene C14orf119, variant not shown         Suspected internal deletion, this clone was ignored    
BF026156 melanotic melanoma, skin Gene C14orf119, variant not shown         Suspected internal deletion, this clone was ignored    
BM673375 eye, eye anterior segment Gene C14orf119, variant not shown       AAA Suspected internal deletion, this clone was ignored    
BM707539 eye, eye anterior segment Gene C14orf119, variant not shown         Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a-u, .b, .c-u, .d Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI